Restructuring drive unlikely to pick up pace

Restructuring of major pharmaceutical firms is expected to lose momentum as they intend to put emphasis on maintaining the number of employees with professional jobs.

Industry sources say pharmaceutical firms have not elaborated on any details regarding restructuring, reflecting the possible layoffs will badly affect their management in the long run, as demonstrated in 1997-98 Asian Financia...